Apoptosis Flashcards
Apoptosis
Programmed cell death
- controlled disassembly of cellular contents without disruption
- no inflammatory response
Why programmed cell death?
- Harmful cells
- Developmentally defective cells
- Excess/unnecessary cells
- Obsolete cells
- Exploitation
Necrosis
-unregulated cell death associated with trauma, cellular disruption and an inflammatory response
Features of necrosis
- plasma membrane becomes permeable
- cell swelling and rupture of cellular membranes
- release of proteases leading to autodigestion and dissolution of the cell
- localised inflammation
Apoptosis phases
- latent phase
- execution phase
Apoptosis latent phase
-death pathways are activated, but cells appear morphologically the same
Apoptosis execution phase
-loss of microvilli and intercellular junctions
-cell shrinkage
-loss of plasma membrane asymmetry (phosphatidylserine lipid appears in outer leaflet)
-chromatin and nuclear condensation
-DNA fragmentation
-formation of membrane blebs
-fragmentation into membrane-enclosed apoptotic bodies
PLASMA MEMBRANE REMAINS INTACT=NO INFLAMMATION
DNA modification in apoptosis
/
Apoptosis-like PCD
- some, but not all, features of apoptosis
- display of phagocytic recognition molecules before plasma membrane lysis
Necrosis-like PCD
- variable features of apoptosis before cell lysis
- ‘aborted apoptosis’
Apoptotic cell death mechanism
- The executioners (Caspases)
- Initiating the death programme (death receptors, mitochondria)
- The Bcl-2 family
- Stopping the death programme
Caspases
Cysteine-dependent aspartate-directed proteases
- executioners of apoptosis
- activated by proteolysis
- cascade of activation
Initiator caspases
-trigger apoptosis by cleaving and activating
Effector caspases
- carry out the apoptotic programme
- cleave and inactive proteins or complexes (eg: nuclear lamins leading to nuclear breakdown)
- activate enzymes (including proteins kinases, nucleases eg: CAD) by direct cleavage, or cleavage of inhibitory molecules
Caspase maturation
-cleavage of the inactive procaspase precursor is followed by folding of 2 large and 2 small chains to form an active L2S2 heterotetramer